Odonate Therapeutics, Inc. (NasdaqGS:ODT), Consolidated-Tomoka Land Co. (AMEX:CTO) ERP5 – A Peek at Valuation

April 14, 2019 06:22 UTC

Trending Today

Backers of $730m Queenstown development hit ground running

India’s High Commissioner to NZ says $33b investment an ‘aspiration’ in free trade agreement, Winston Peters says it’s ‘hard commitment’

Councillors to be briefed on unitary authorities

Remand prisoner convinces ex-partner to withdraw family violence charges with threat of a ‘bullet’

Odonate Therapeutics, Inc. (NasdaqGS:ODT), Consolidated-Tomoka Land Co. (AMEX:CTO) ERP5 – A Peek at Valuation

Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity. The Earnings to Price yield of Odonate Therapeutics, Inc. (NasdaqGS:ODT) is -0.132995. The Earnings Yield for Odonate Therapeutics, Inc. (NasdaqGS:ODT) is -0.160499. RatiosThe Current Ratio of Odonate Therapeutics, Inc. (NasdaqGS:ODT) is 7.68. The price to earnings ratio for Consolidated-Tomoka Land Co. (AMEX:CTO) is 8.839877.

Source: Otago Daily Times April 14, 2019 06:22 UTC

One month on from Christchurch mosque shootings, big changes are still coming

Trump-themed Cantonese opera takes China by storm

Southland's Rose of Tralee Caitlin Mahon celebrates her heritage